4.8 Review

Quantum dot-based theranostics

Journal

NANOSCALE
Volume 2, Issue 1, Pages 60-68

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/b9nr00178f

Keywords

-

Funding

  1. NIH [EB002849, HL-89764]
  2. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089764] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002849] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Luminescent semiconductor nanocrystals, also known as quantum dots (QDs), have advanced the fields of molecular diagnostics and nanotherapeutics. Much of the initial progress for QDs in biology and medicine has focused on developing new biosensing formats to push the limit of detection sensitivity. Nevertheless. QDs can be more than passive bio-probes or labels for biological imaging and cellular studies. The high surface-to-volume ratio of QDs enables the construction of a smart multifunctional nanoplatform, where the QDs serve not only as an imaging agent but also a nanoscaffold catering for therapeutic and diagnostic (theranostic) modalities. This mini review highlights the emerging applications of functionalized QDs as fluorescence contrast agents for imaging or as nanoscale vehicles for delivery of therapeutics, with special attention paid to the promise and challenges towards QD-based theranostics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available